Check-Cap CHEK - Daily June 2021CHEK will be looking for FDA approval by early 2023. US Pivotal Study will take place in 2022.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−17.57 M USD
0.00 USD
4.38 M
About Check-Cap Ltd.
Sector
Industry
CEO
Saar Levi
Website
Headquarters
Isfiya
Founded
2005
ISIN
IL0011336851
FIGI
BBG0089RJVS4
Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule systems for colorectal cancer screening. Its patented technology, C-Scan, is a patient-friendly preparation-free test designed to detect polyps before they may transform into cancer. The company was founded by Yoav Kimchy in 2005 and is headquartered in Isfiya, Israel.
Chek Harmonics: Fishing for Round ThreeHere, we have what appears to be a clear 3-drive pattern. I noticed that each spike is on a Monday, within one plus or minus approximately 1 week of a quadruple witching day. Furthermore, time ratios indicated the pop COULD happen anytime between the purple vertical lines; however, the pattern is
$CHEK PT 5 and way higherCheck-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based system that utilizes low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X
Third Technical Analysis - CHEK Based on the historical data that the chart presents, the bottom of the trend is estimated to be at $1.92; however, there is both technical and psychological support at $ 2. This indicates there could be a slight dip under $2 temporarily in the upcoming days ( however, this seems unlikely ). Followi
Chek Harmonics: 1-2-3 Go!It's a long wait here, from this perspective, but the entry and quick exit would be a phenomenal trade. Check it out and load up when price satisfies the buy zone criteria and when the timing is right!
$CHEK Receives FDA IDE Approval for Pivotal Study of C-Scan®Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan®
today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational Device Exemption (IDE) application, permitting Check-Cap to begin a pivotal study of C-Scan in the U.S.
The pivotal study wil
premarket mover, possible targets $9, $12Please note:
- I'm just sharing my view. its not a recommendation for buying or selling.
- penny stocks moves most of the times are " pump n dump". don't chase them, and you must have an exit plan.
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CHEK is 1.58 USD — it has decreased by −34.67% in the past 24 hours. Watch Check-Cap Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Check-Cap Ltd. stocks are traded under the ticker CHEK.
CHEK stock has risen by 140.55% compared to the previous week, the month change is a 80.50% rise, over the last year Check-Cap Ltd. has showed a −21.39% decrease.
CHEK reached its all-time high on Mar 18, 2015 with the price of 1,512.60 USD, and its all-time low was 0.56 USD and was reached on Dec 20, 2024. View more price dynamics on CHEK chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CHEK stock is 80.00% volatile and has beta coefficient of 0.84. Track Check-Cap Ltd. stock price on the chart and check out the list of the most volatile stocks — is Check-Cap Ltd. there?
Today Check-Cap Ltd. has the market capitalization of 13.16 M, it has decreased by −6.01% over the last week.
Yes, you can track Check-Cap Ltd. financials in yearly and quarterly reports right on TradingView.
Check-Cap Ltd. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
No, CHEK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CHEK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Check-Cap Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Check-Cap Ltd. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Check-Cap Ltd. stock shows the sell signal. See more of Check-Cap Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.